A citation-based method for searching scientific literature

Caroline S Bennette, Carlos J Gallego, Wylie Burke, Gail P Jarvik, David L Veenstra. Genet Med 2015
Times Cited: 65







List of co-cited articles
416 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
47

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
831
26

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
23

Molecular findings among patients referred for clinical whole-exome sequencing.
Yaping Yang, Donna M Muzny, Fan Xia, Zhiyv Niu, Richard Person, Yan Ding, Patricia Ward, Alicia Braxton, Min Wang, Christian Buhay,[...]. JAMA 2014
809
18

Actionable, pathogenic incidental findings in 1,000 participants' exomes.
Michael O Dorschner, Laura M Amendola, Emily H Turner, Peggy D Robertson, Brian H Shirts, Carlos J Gallego, Robin L Bennett, Kelly L Jones, Mari J Tokita, James T Bennett,[...]. Am J Hum Genet 2013
270
13

Actionable exomic incidental findings in 6503 participants: challenges of variant classification.
Laura M Amendola, Michael O Dorschner, Peggy D Robertson, Joseph S Salama, Ragan Hart, Brian H Shirts, Mitzi L Murray, Mari J Tokita, Carlos J Gallego, Daniel Seung Kim,[...]. Genome Res 2015
224
13

Assessing the Costs and Cost-Effectiveness of Genomic Sequencing.
Kurt D Christensen, Dmitry Dukhovny, Uwe Siebert, Robert C Green. J Pers Med 2015
58
15

Recommendations for returning genomic incidental findings? We need to talk!
Wylie Burke, Armand H Matheny Antommaria, Robin Bennett, Jeffrey Botkin, Ellen Wright Clayton, Gail E Henderson, Ingrid A Holm, Gail P Jarvik, Muin J Khoury, Bartha Maria Knoppers,[...]. Genet Med 2013
213
12

Attitudes of genetics professionals toward the return of incidental results from exome and whole-genome sequencing.
Joon-Ho Yu, Tanya M Harrell, Seema M Jamal, Holly K Tabor, Michael J Bamshad. Am J Hum Genet 2014
86
12

Clinical exome sequencing for genetic identification of rare Mendelian disorders.
Hane Lee, Joshua L Deignan, Naghmeh Dorrani, Samuel P Strom, Sibel Kantarci, Fabiola Quintero-Rivera, Kingshuk Das, Traci Toy, Bret Harry, Michael Yourshaw,[...]. JAMA 2014
570
12

Issues surrounding the health economic evaluation of genomic technologies.
James Buchanan, Sarah Wordsworth, Anna Schuh. Pharmacogenomics 2013
62
12

Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis.
Carlos J Gallego, Brian H Shirts, Caroline S Bennette, Greg Guzauskas, Laura M Amendola, Martha Horike-Pyne, Fuki M Hisama, Colin C Pritchard, William M Grady, Wylie Burke,[...]. J Clin Oncol 2015
88
12

Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement.
Zornitza Stark, Deborah Schofield, Khurshid Alam, William Wilson, Nessie Mupfeki, Ivan Macciocca, Rupendra Shrestha, Susan M White, Clara Gaff. Genet Med 2017
115
12

Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature.
Katharina Schwarze, James Buchanan, Jenny C Taylor, Sarah Wordsworth. Genet Med 2018
185
12


The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine.
Jason L Vassy, Denise M Lautenbach, Heather M McLaughlin, Sek Won Kong, Kurt D Christensen, Joel Krier, Isaac S Kohane, Lindsay Z Feuerman, Jennifer Blumenthal-Barby, J Scott Roberts,[...]. Trials 2014
102
10

A systematic approach to the reporting of medically relevant findings from whole genome sequencing.
Heather M McLaughlin, Ozge Ceyhan-Birsoy, Kurt D Christensen, Isaac S Kohane, Joel Krier, William J Lane, Denise Lautenbach, Matthew S Lebo, Kalotina Machini, Calum A MacRae,[...]. BMC Med Genet 2014
61
11

Clinical whole-exome sequencing for the diagnosis of mendelian disorders.
Yaping Yang, Donna M Muzny, Jeffrey G Reid, Matthew N Bainbridge, Alecia Willis, Patricia A Ward, Alicia Braxton, Joke Beuten, Fan Xia, Zhiyv Niu,[...]. N Engl J Med 2013
10

Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review.
Michael P Douglas, Uri Ladabaum, Mark J Pletcher, Deborah A Marshall, Kathryn A Phillips. Genet Med 2016
16
43

Cost analysis of whole genome sequencing in German clinical practice.
Marika Plöthner, Martin Frank, J-Matthias Graf von der Schulenburg. Eur J Health Econ 2017
18
38

Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.
Jonathan S Berg, Laura M Amendola, Christine Eng, Eliezer Van Allen, Stacy W Gray, Nikhil Wagle, Heidi L Rehm, Elizabeth T DeChene, Matthew C Dulik, Fuki M Hisama,[...]. Genet Med 2013
88
9

ACMG clinical laboratory standards for next-generation sequencing.
Heidi L Rehm, Sherri J Bale, Pinar Bayrak-Toydemir, Jonathan S Berg, Kerry K Brown, Joshua L Deignan, Michael J Friez, Birgit H Funke, Madhuri R Hegde, Elaine Lyon. Genet Med 2013
532
9

Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders.
Sarah E Soden, Carol J Saunders, Laurel K Willig, Emily G Farrow, Laurie D Smith, Josh E Petrikin, Jean-Baptiste LePichon, Neil A Miller, Isabelle Thiffault, Darrell L Dinwiddie,[...]. Sci Transl Med 2014
317
9

ClinGen--the Clinical Genome Resource.
Heidi L Rehm, Jonathan S Berg, Lisa D Brooks, Carlos D Bustamante, James P Evans, Melissa J Landrum, David H Ledbetter, Donna R Maglott, Christa Lese Martin, Robert L Nussbaum,[...]. N Engl J Med 2015
502
9

Clinical Impact and Cost-Effectiveness of Whole Exome Sequencing as a Diagnostic Tool: A Pediatric Center's Experience.
C Alexander Valencia, Ammar Husami, Jennifer Holle, Judith A Johnson, Yaping Qian, Abhinav Mathur, Chao Wei, Subba Rao Indugula, Fanggeng Zou, Haiying Meng,[...]. Front Pediatr 2015
105
9


Cost Effectiveness of Sequencing 34 Cancer-Associated Genes as an Aid for Treatment Selection in Patients with Metastatic Melanoma.
Yonghong Li, Lance A Bare, Richard A Bender, John J Sninsky, Leslie S Wilson, James J Devlin, Frederic M Waldman. Mol Diagn Ther 2015
21
28

Genomic Sequencing Procedure Microcosting Analysis and Health Economic Cost-Impact Analysis: A Report of the Association for Molecular Pathology.
Linda M Sabatini, Charles Mathews, Devon Ptak, Shivang Doshi, Katherine Tynan, Madhuri R Hegde, Tara L Burke, Aaron D Bossler. J Mol Diagn 2016
52
11

Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing.
Kirsten J M van Nimwegen, Ronald A van Soest, Joris A Veltman, Marcel R Nelen, Gert Jan van der Wilt, Lisenka E L M Vissers, Janneke P C Grutters. Clin Chem 2016
67
9

A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorder.
Kate Tsiplova, Richard M Zur, Christian R Marshall, Dimitri J Stavropoulos, Sergio L Pereira, Daniele Merico, Edwin J Young, Wilson W L Sung, Stephen W Scherer, Wendy J Ungar. Genet Med 2017
41
14

The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial.
Jason L Vassy, Kurt D Christensen, Erica F Schonman, Carrie L Blout, Jill O Robinson, Joel B Krier, Pamela M Diamond, Matthew Lebo, Kalotina Machini, Danielle R Azzariti,[...]. Ann Intern Med 2017
100
9

Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes.
Jennifer J Johnston, Wendy S Rubinstein, Flavia M Facio, David Ng, Larry N Singh, Jamie K Teer, James C Mullikin, Leslie G Biesecker. Am J Hum Genet 2012
159
7


The economic value of personalized medicine tests: what we know and what we need to know.
Kathryn A Phillips, Julie Ann Sakowski, Julia Trosman, Michael P Douglas, Su-Ying Liang, Peter Neumann. Genet Med 2014
66
7

Diagnostic exome sequencing in persons with severe intellectual disability.
Joep de Ligt, Marjolein H Willemsen, Bregje W M van Bon, Tjitske Kleefstra, Helger G Yntema, Thessa Kroes, Anneke T Vulto-van Silfhout, David A Koolen, Petra de Vries, Christian Gilissen,[...]. N Engl J Med 2012
970
7

Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care.
S L Sawyer, T Hartley, D A Dyment, C L Beaulieu, J Schwartzentruber, A Smith, H M Bedford, G Bernard, F P Bernier, B Brais,[...]. Clin Genet 2016
203
7

Researchers' views on return of incidental genomic research results: qualitative and quantitative findings.
Robert Klitzman, Paul S Appelbaum, Abby Fyer, Josue Martinez, Brigitte Buquez, Julia Wynn, Cameron R Waldman, Jo Phelan, Erik Parens, Wendy K Chung. Genet Med 2013
83
7

Diagnostic clinical genome and exome sequencing.
Leslie G Biesecker, Robert C Green. N Engl J Med 2014
344
7

Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics.
Carla G van El, Martina C Cornel, Pascal Borry, Ros J Hastings, Florence Fellmann, Shirley V Hodgson, Heidi C Howard, Anne Cambon-Thomsen, Bartha M Knoppers, Hanne Meijers-Heijboer,[...]. Eur J Hum Genet 2013
207
7

Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research.
Anna Middleton, Katherine I Morley, Eugene Bragin, Helen V Firth, Matthew E Hurles, Caroline F Wright, Michael Parker. Eur J Hum Genet 2016
111
7

A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing.
Jonathan S Berg, Ann Katherine M Foreman, Julianne M O'Daniel, Jessica K Booker, Lacey Boshe, Timothy Carey, Kristy R Crooks, Brian C Jensen, Eric T Juengst, Kristy Lee,[...]. Genet Med 2016
53
9

The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers.
Deirdre Weymann, Janessa Laskin, Robyn Roscoe, Kasmintan A Schrader, Stephen Chia, Stephen Yip, Winson Y Cheung, Karen A Gelmon, Aly Karsan, Daniel J Renouf,[...]. Mol Genet Genomic Med 2017
24
20

Genome sequencing: a systematic review of health economic evidence.
Martin Frank, Anne Prenzler, Roland Eils, J-Matthias Graf von der Schulenburg. Health Econ Rev 2013
35
14

Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants.
Kandamurugu Manickam, Adam H Buchanan, Marci L B Schwartz, Miranda L G Hallquist, Janet L Williams, Alanna Kulchak Rahm, Heather Rocha, Juliann M Savatt, Alyson E Evans, Loren M Butry,[...]. JAMA Netw Open 2018
78
7

Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate.
Timothy Caulfield, Jim Evans, Amy McGuire, Christopher McCabe, Tania Bubela, Robert Cook-Deegan, Jennifer Fishman, Stuart Hogarth, Fiona A Miller, Vardit Ravitsky,[...]. PLoS Biol 2013
52
7

Genomic sequencing: assessing the health care system, policy, and big-data implications.
Kathryn A Phillips, Julia R Trosman, Robin K Kelley, Mark J Pletcher, Michael P Douglas, Christine B Weldon. Health Aff (Millwood) 2014
29
13

Key emerging themes for assessing the cost-effectiveness of reporting incidental findings.
Kathryn A Phillips, Uri Ladabaum, Mark J Pletcher, Deborah A Marshall, Michael P Douglas. Genet Med 2015
4
100

Parental attitudes, values, and beliefs toward the return of results from exome sequencing in children.
J C Sapp, D Dong, C Stark, L E Ivey, G Hooker, L G Biesecker, B B Biesecker. Clin Genet 2014
86
6

Lynch syndrome patients' views of and preferences for return of results following whole exome sequencing.
Kelly Hitch, Galen Joseph, Jenna Guiltinan, Jessica Kianmahd, Janey Youngblom, Amie Blanco. J Genet Couns 2014
45
8



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.